Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Self-Monitoring Blood Glucose Devices Market: By Product, By End Users and Geography
Self-Monitoring Blood Glucose Devices Market size was valued at US$ 13.12 billion in 2023. It is expected to reach a value of US$ 23.84 billion by 2024, at a significant CAGR of 9.2% from 2024-2030. Self-monitoring blood glucose technology methods are small, portable devices that can detect disease risk. These instruments often take a tiny blood sample from patients by pricking their fingertips in order to measure their blood sugar levels. This approach is advised by international recommendations for effectively managing diabetes in patients. The blood glucose concentration is measured using a self-monitoring blood glucose monitor. The COVID-19 pandemic had a favourable effect on the expansion of the self-monitoring blood glucose market. Diabetes problems, aberrant glucose variability, and increased blood glucose levels may be experienced by COVID-19-infected patients who have diabetes.
The COVID-19 emergency has highlighted the significance of self-monitoring blood glucose devices, therefore it is important to keep an eye on a patient's blood glucose monitoring to prevent aggravation. Going forward, it is anticipated that the market for self-monitoring blood glucose devices would expand due to the increased prevalence of diabetes. Self-monitoring of blood glucose is a technique whereby a person with diabetes uses a glycemic reading device to measure their blood sugar (glucose metre) so that they can adjust or monitor the effectiveness of their treatment (diet, exercise, insulin, antidiabetics), or see their doctor, based on the test results.
Study Period
2024-2030Base Year
2023CAGR
9.2%Largest Market
North-AmericaFastest Growing Market
Europe
A substantial proportion of persons in the United States carry genes for bleeding and clotting diseases, as well as hemoglobinopathies, according to the Office of Disease Prevention and Health Promotion. Blood clots in leg veins affect over 1.2 million people in the United States. Deep venous thrombosis is the medical term for this illness (DVT). Hemoglobin disorders were once endemic in 60 percent of 229 countries, potentially affecting 75 percent of births.
however, they are now common in 71 percent of countries, affecting 89 percent of births (either in the entire population or among minorities), prompting policymakers to consider the most appropriate treatment and prevention strategy. A major variation affects at least 5.2 percent of the world's population (and over 7% of pregnant women). Due to a localised very high carrier prevalence, haemoglobin S accounts for 40% of carriers but causes over 80% of problems: over 85% of sickle-cell disorders and over 70% of all affected infants occur in Africa. As a result, the market is likely to be driven by increased blood diseases.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 13.12 billion |
Market CAGR |
9.2% |
By Product |
|
By End User |
|
By Region |
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
|
Download Free Sample Report
The Self-monitoring blood glucose devices market size was valued at US$ 13.12 million in 2023 and is expected to reach US$ 23.84 billion by 2030, at a CAGR of 9.2%.
The key segments covered in the market are technology, components, application, and end-users.
The market key players Abbott Laboratories (U.S.), ARKRAY, Inc. (Japan), Bayer AG (Germany), Dexcom, Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic plc (U.S.), Nipro Diagnostics, Inc. (U.S.), Terumo Medical Corporation (U.S.)
1.Executive Summary |
2.Global Self-Monitoring Blood Glucose Devices Market Introduction |
2.1.Global Self-Monitoring Blood Glucose Devices Market - Taxonomy |
2.2.Global Self-Monitoring Blood Glucose Devices Market - Definitions |
2.2.1.Product |
2.2.2.End User |
2.2.3.Region |
3.Global Self-Monitoring Blood Glucose Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Self-Monitoring Blood Glucose Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Self-Monitoring Blood Glucose Devices Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Blood Glucose Meter |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Blood Glucose Testing Strips |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Lancets |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Self-Monitoring Blood Glucose Devices Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Clinics |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Diagnostic Centers |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Homecare |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Self-Monitoring Blood Glucose Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Self-Monitoring Blood Glucose Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Blood Glucose Meter |
8.1.2.Blood Glucose Testing Strips |
8.1.3.Lancets |
8.1.4.Others |
8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospitals |
8.2.2.Clinics |
8.2.3.Diagnostic Centers |
8.2.4.Homecare |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Self-Monitoring Blood Glucose Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Blood Glucose Meter |
9.1.2.Blood Glucose Testing Strips |
9.1.3.Lancets |
9.1.4.Others |
9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospitals |
9.2.2.Clinics |
9.2.3.Diagnostic Centers |
9.2.4.Homecare |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10.Asia Pacific (APAC) Self-Monitoring Blood Glucose Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Blood Glucose Meter |
10.1.2.Blood Glucose Testing Strips |
10.1.3.Lancets |
10.1.4.Others |
10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospitals |
10.2.2.Clinics |
10.2.3.Diagnostic Centers |
10.2.4.Homecare |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Self-Monitoring Blood Glucose Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Blood Glucose Meter |
11.1.2.Blood Glucose Testing Strips |
11.1.3.Lancets |
11.1.4.Others |
11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospitals |
11.2.2.Clinics |
11.2.3.Diagnostic Centers |
11.2.4.Homecare |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Self-Monitoring Blood Glucose Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Blood Glucose Meter |
12.1.2.Blood Glucose Testing Strips |
12.1.3.Lancets |
12.1.4.Others |
12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospitals |
12.2.2.Clinics |
12.2.3.Diagnostic Centers |
12.2.4.Homecare |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Abbott Laboratories (U.S.) |
13.2.2.ARKRAY, Inc. (Japan) |
13.2.3.Bayer AG (Germany) |
13.2.4.Dexcom, Inc. (U.S.) |
13.2.5.Hoffmann-La Roche Ltd (Switzerland) |
13.2.6.Johnson & Johnson (U.S.) |
13.2.7.Medtronic plc (U.S.) |
13.2.8.Nipro Diagnostics, Inc. (U.S.) |
13.2.9.Terumo Medical Corporation (U.S.) |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players